Universe · entity
DEERFIELD MANAGEMENT COMPANY, L.P.
Institutional manager (13F) · CIK 1009258
13F holdings · as of 2026-03-31 · top 50 · reported portfolio $8.0B
| # | Issuer | Value | Shares |
|---|---|---|---|
| 1 | NUVALENT INC | $1.8B | 17,248,450 |
| 2 | BROOKDALE SR LIVING INC | $505M | 306,885,000 |
| 3 | COGENT BIOSCIENCES INC | $348M | 9,043,903 |
| 4 | PRAXIS PRECISION MEDICINES I | $310M | 963,351 |
| 5 | VIATRIS INC | $273M | 20,206,170 |
| 6 | UNITED THERAPEUTICS CORP DEL | $271M | 457,000 |
| 7 | REVOLUTION MEDICINES INC | $223M | 2,297,000 |
| 8 | MIRUM PHARMACEUTICALS INC | $209M | 70,000,000 |
| 9 | ARROWHEAD PHARMACEUTICALS IN | $207M | 200,000,000 |
| 10 | CELCUITY INC | $196M | 1,714,000 |
| 11 | CENTENE CORP DEL | $194M | 5,917,091 |
| 12 | LARIMAR THERAPEUTICS INC | $160M | 35,606,974 |
| 13 | BROOKDALE SR LIVING INC | $159M | 11,637,032 |
| 14 | VERA THERAPEUTICS INC | $150M | 3,722,100 |
| 15 | IONIS PHARMACEUTICALS INC | $149M | 1,979,669 |
| 16 | BIOCRYST PHARMACEUTICALS INC | $143M | 15,038,000 |
| 17 | INSPIRE MED SYS INC | $139M | 2,703,238 |
| 18 | LEGEND BIOTECH CORP | $139M | 7,687,638 |
| 19 | ADAPTHEALTH CORP | $137M | 11,477,730 |
| 20 | NEWAMSTERDAM PHARMA COMPANY | $137M | 4,264,789 |
| 21 | ACADIA HEALTHCARE COMPANY IN | $106M | 4,520,000 |
| 22 | ARROWHEAD PHARMACEUTICALS IN | $99M | 1,573,297 |
| 23 | CATALYST PHARMACEUTICALS INC | $98M | 3,943,600 |
| 24 | INDIVIOR PHARMACEUTICALS INC | $94M | 3,097,790 |
| 25 | XENON PHARMACEUTICALS INC | $94M | 1,615,696 |
| 26 | IONIS PHARMACEUTICALS INC | $91M | 60,000,000 |
| 27 | PHARVARIS N V | $88M | 3,126,042 |
| 28 | SYNDAX PHARMACEUTICALS INC | $88M | 3,779,900 |
| 29 | TANGO THERAPEUTICS INC | $87M | 4,146,813 |
| 30 | ALIGNMENT HEALTHCARE INC | $86M | 61,000,000 |
| 31 | DIANTHUS THERAPEUTICS INC | $86M | 1,019,813 |
| 32 | PFIZER INC | $85M | 3,040,000 |
| 33 | NEUROCRINE BIOSCIENCES INC | $80M | 610,000 |
| 34 | DAY ONE BIOPHARMACEUTICALS I | $80M | 3,723,131 |
| 35 | SAVARA INC | $74M | 13,569,000 |
| 36 | ZENAS BIOPHARMA INC | $67M | 65,000,000 |
| 37 | ENHABIT INC | $67M | 4,747,746 |
| 38 | NEOGENOMICS INC | $67M | 72,689,000 |
| 39 | GENMAB A/S | $66M | 2,462,000 |
| 40 | BIO RAD LABS INC | $63M | 226,070 |
| 41 | LANTHEUS HLDGS INC | $63M | 827,999 |
| 42 | ARS PHARMACEUTICALS INC | $60M | 7,503,812 |
| 43 | STOKE THERAPEUTICS INC | $59M | 1,823,500 |
| 44 | ENVISTA HOLDINGS CORPORATION | $56M | 2,210,100 |
| 45 | IDEAYA BIOSCIENCES INC | $51M | 1,530,008 |
| 46 | BELITE BIO INC | $48M | 304,013 |
| 47 | BIOMARIN PHARMACEUTICAL INC | $48M | 851,556 |
| 48 | KYMERA THERAPEUTICS INC | $47M | 561,170 |
| 49 | CERTARA INC | $45M | 7,808,605 |
| 50 | BRIDGEBIO ONCOLOGY THERAPEUT | $44M | 4,885,446 |
Source: sec_edgar_13f · public regulatory · retrieved 2026-06-29. Public SEC data; no contact information.